Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06074380 · ClinicalTrials.gov registry record · Phase 4
Non Inferiority Trial Investigating Surfactants Administered Via MIST
A Phase 4 study of Respiratory Distress Syndrome, sponsored by Endeavor Health.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 262
- Enrollment target
- 1
- Study location
NCT06074380 is a Phase 4 study of Respiratory Distress Syndrome that is actively recruiting participants, run by Endeavor Health. The registered enrollment target is 262 participants, above the 202-participant average among 8 other Respiratory Distress Syndrome trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06074380, a Phase 4 study of Respiratory Distress Syndrome, is actively recruiting participants, sponsored by Endeavor Health.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 262 participants
- Enrollment target
- 1
- Study location
Study Summary
RESEARCH DESIGN Multicenter, randomized, controlled trial. RECRUITMENT Entry criteria Preterm infants 28-35 6/7 weeks' gestation and less than 48 hours of age who have a clinical diagnosis of respiratory distress syndrome. Infants who are on NCPAP and FiO2 ≥0.30 will randomized to curosurf or infasurf via MIST. Exclusion criteria Infants will be excluded if there is a congenital anomaly or an alternative cause for respiratory distress. Babies who require emergent intubation will not be enrolled in the interventions. Parental Consent will be obtained prior to randomization.
Conditions Studied
Interventions
- DRUG MIST surfactant
Study Locations (1)
Illinois
- Northshore University Healthsystem - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2027-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06074380
The ClinicalTrials.gov registry entry for NCT06074380 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 202-participant average among 8 other Respiratory Distress Syndrome trials with a reported enrollment target (30% higher). The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Respiratory Distress Syndrome appearing as the primary indexed condition, and to 1 intervention - of which MIST surfactant is the first listed.
NCT06074380 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06074380 about?
NCT06074380 is a clinical study titled "Non Inferiority Trial Investigating Surfactants Administered Via MIST". RESEARCH DESIGN Multicenter, randomized, controlled trial. RECRUITMENT Entry criteria Preterm infants 28-35 6/7 weeks' gestation and less than 48 hours of age who have a clinical diagnosis of respiratory distress syndrome. Infants who are on NCPAP and FiO2 ≥0.30 will randomized to curosurf or infasu...
What is the current status of trial NCT06074380?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 262 participants. The study started on 2024-01-01. Estimated completion is 2027-12-01.
What conditions does trial NCT06074380 study?
This clinical trial studies the following conditions: Respiratory Distress Syndrome.
What interventions are being tested in trial NCT06074380?
The interventions under investigation include: MIST surfactant (DRUG).
Who is sponsoring clinical trial NCT06074380?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06074380 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Distress Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
RECRUITING
-
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
RECRUITING · Phase 3
-
Spinal Cord Stimulation to Shorten Ventilator Dependence in ARDS Patients
RECRUITING · NA
-
The Budesonide in Babies (BiB) Trial
ACTIVE NOT RECRUITING · Phase 3
-
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
COMPLETED · Phase 1
-
The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.